Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

Completed · Phase 2

Conditions studied: Diabetes Mellitus, Non-Insulin-Dependent

In brief

This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication

Key facts

Study ID

NCT00044707

Run by

AstraZeneca

People needed

24

Starts

2002-08-01

Expected to finish

2002-09-01

Last updated by the study team

2015-05-21

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes mellitus treated with diet and/or oral agents
• HbA1c 6.5-11.0

Where it is running

• ICSL-Clinical Studies — Fort Lauderdale, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.